Status:

UNKNOWN

Efficacy of Two Prophylactic Schedules (Prulifloxacin Versus Phosphomycin)

Lead Sponsor:

University Of Perugia

Conditions:

Urinary Tract Infection

Eligibility:

FEMALE

18-75 years

Phase:

PHASE2

Brief Summary

Epidemiological studies showed that 20-30% of patients with uncomplicated urinary tract infections risked recurrent infection. Urinary tract infection causes marked discomfort for the patient, has a n...

Eligibility Criteria

Inclusion

  • Female patients
  • Age over 18 years old
  • No allergies to the drugs to be prescribed
  • No counter-indications to this drug therapy
  • Urine culture shows responsiveness to drugs at recruitment of patient
  • History of urinary tract infections with at least three episodes in the previous year or two in the past six months

Exclusion

  • Lack of tolerability of prescribed drugs

Key Trial Info

Start Date :

November 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2012

Estimated Enrollment :

96 Patients enrolled

Trial Details

Trial ID

NCT01231737

Start Date

November 1 2010

End Date

February 1 2012

Last Update

November 1 2010

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Efficacy of Two Prophylactic Schedules (Prulifloxacin Versus Phosphomycin) | DecenTrialz